Distinguished in Cerebellum Agenesis Hydrocephaly

Dr. William T. Curry

Neurosurgery
Massachusetts General Physicians Organization Inc
55 Fruit St, 
Boston, MA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Distinguished in Cerebellum Agenesis Hydrocephaly
Massachusetts General Physicians Organization Inc
55 Fruit St, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Curry is a Neurosurgery provider in Boston, Massachusetts. Dr. Curry is rated as a Distinguished provider by MediFind in the treatment of Cerebellum Agenesis Hydrocephaly. His top areas of expertise are Glioblastoma, Astrocytoma, Meningioma, Awake Craniotomy, and Septoplasty. Dr. Curry is currently accepting new patients.

His clinical research consists of co-authoring 155 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurosurgery
Licenses
Neurological Surgery in MA
Hospital Affiliations
Massachusetts General Hospital
North Shore Medical Center -
Brigham And Women's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Neighborhood
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Tufts
  • HMO

Locations

MASSACHUSETTS GENERAL PHYSICIANS ORGANIZATION INC
55 Fruit St, Boston, MA 02114

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Long-term Follow-up of Subjects Treated With CAR T Cells
Long-term Follow-up of Subjects Treated With CAR T Cells
Enrollment Status: Recruiting
Publish Date: October 01, 2025
Intervention Type: Diagnostic test, Procedure
A Phase II Study of the Safety and Efficacy of SVN53-67/M57-KLH (SurVaxM) in Survivin-Positive Newly Diagnosed Glioblastoma
A Phase II Study of the Safety and Efficacy of SVN53-67/M57-KLH (SurVaxM) in Survivin-Positive Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
Intervention Type: Biological, Drug, Other
Study Drugs: Montanide ISA 51 VG, Sargramostim, SVN53-67/M57-KLH Peptide Vaccine, Temozolomide
Study Phase: Phase 2
A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
Enrollment Status: Completed
Publish Date: July 11, 2025
Intervention Type: Biological, Drug
Study Drug: Oncolytic Polio/Rhinovirus Recombinant Vaccine
Study Phase: Phase 2
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: June 05, 2025
Intervention Type: Biological
Study Drugs: PVSRIPO, Pembrolizumab
Study Phase: Phase 2
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
Enrollment Status: Terminated
Publish Date: January 24, 2025
Intervention Type: Biological, Drug
Study Drugs: HSPPC-96, Bevacizumab
Study Phase: Phase 2
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
Enrollment Status: Completed
Publish Date: April 28, 2020
Intervention Type: Radiation, Other, Biological
Study Phase: Not Applicable
A Phase I Study of Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
A Phase I Study of Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
Enrollment Status: Completed
Publish Date: June 22, 2017
Intervention Type: Biological
Study Phase: Phase 1
View 7 Less Clinical Trials

155 Total Publications

Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM.
Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM.
Journal: Cancer immunology, immunotherapy : CII
Published: August 15, 2025
Similar Doctors
Distinguished in Cerebellum Agenesis Hydrocephaly
Dr. Garth R. Cosgrove
Neurosurgery
Distinguished in Cerebellum Agenesis Hydrocephaly
Dr. Garth R. Cosgrove
Neurosurgery

Brigham And Womens Physicians Organization Inc

75 Francis St, 
Boston, MA 
 (2.7 miles away)
617-732-5500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Garth Cosgrove is a Neurosurgery provider in Boston, Massachusetts. Dr. Cosgrove is rated as an Elite provider by MediFind in the treatment of Cerebellum Agenesis Hydrocephaly. His top areas of expertise are Essential Tremor, Seizures, Cerebellum Agenesis Hydrocephaly, Thalamotomy, and Deep Brain Stimulation. Dr. Cosgrove is currently accepting new patients.

Distinguished in Cerebellum Agenesis Hydrocephaly
Dr. Alexandra J. Golby
Neurosurgery | Neurology
Distinguished in Cerebellum Agenesis Hydrocephaly
Dr. Alexandra J. Golby
Neurosurgery | Neurology

Brigham And Womens Physicians Organization Inc

75 Francis St, 
Boston, MA 
 (2.7 miles away)
617-732-5500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alexandra Golby is a Neurosurgery specialist and a Neurologist in Boston, Massachusetts. Dr. Golby is rated as a Distinguished provider by MediFind in the treatment of Cerebellum Agenesis Hydrocephaly. Her top areas of expertise are Brain Tumor, Hydrocephalus, Normal Pressure Hydrocephalus, Awake Craniotomy, and Vitrectomy. Dr. Golby is currently accepting new patients.

Distinguished in Cerebellum Agenesis Hydrocephaly
Dr. Petra M. Klinge
Neurosurgery
Distinguished in Cerebellum Agenesis Hydrocephaly
Dr. Petra M. Klinge
Neurosurgery

Lifespan Physician Group Inc

185 High Service Ave, 
North Providence, RI 
 (40.3 miles away)
401-354-6050
Languages Spoken:
English
See accepted insurances

Petra Klinge is a Neurosurgery provider in North Providence, Rhode Island. Dr. Klinge is rated as an Elite provider by MediFind in the treatment of Cerebellum Agenesis Hydrocephaly. Her top areas of expertise are Tethered Cord Syndrome, Hydrocephalus, Normal Pressure Hydrocephalus, Posterior Fossa Decompression, and Laminectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Curry's expertise for a condition
ConditionClose
View All 18 Distinguished Conditions
View All 16 Advanced Conditions
View All 33 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile